Gross Margin

As Calix announces its Q4 earnings date and a major Investor Day, all eyes are on its agentic AI platform and strategy to redefine broadband services.

China's JIADE LIMITED partners with South Korea's Chinalink, leveraging AI to expand education services to North America, Asia, and the Middle East.

SPAR Group appoints a CPG veteran to lead North American sales while top executives make significant share purchases, signaling strong internal confidence.

Cinemark expands its hit 'Bring Your Own Bucket' event with a Lowe's partnership, offering massive popcorn fills for just $5. Here's the inside scoop.

HVAC/R giant Watsco extends its 52-year dividend streak, signaling robust financial health and a strategy built on market consolidation and AI.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

Innocan Pharma is set to debut on the NYSE American, aiming to boost its innovative CBD drug delivery platform for non-opioid pain relief. What's next?

Despite falling revenue and supply chain chaos, CanadaBis posts positive cash flow, signaling a disciplined new strategy for survival and sustainability.

With a 79% drop in net loss and a fourth straight growth quarter, supplement maker Vitality Products Inc. bets on new hires to conquer online and retail.

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

Facing market headwinds, tea supplier Oriental Rise makes a bold move to acquire a major producer, aiming to secure its supply chain and boost quality.

Profound Medical raises over $42M to advance its AI-powered, incision-free therapies for cancer and other diseases, signaling strong investor confidence.

Customers face a 3% interim water rate hike in January as regulators review a plan that could see bills climb over 30% to fund infrastructure.

Riding a wave of record revenue and a favorable reimbursement outlook, iRhythm's upcoming JPM presentation is a key test for its 2026 growth strategy.

After eliminating over $10.7M in debt, cannabis operator LEEF Brands leverages strong Q3 growth to fuel major expansion in California and New York.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A new report details how interconnected apps, wearables, and AI are creating a 'Human Performance Economy' that extends far beyond the gym's walls.

With promising survival data and a pivotal Phase 3 trial underway, Imunon's localized immunotherapy could finally change the game for ovarian cancer.

With a new HQ and $2M in contracts, Taoping is leveraging AI and government policy to modernize China's aging elevators, but faces investor scrutiny.